NOVARTIS AG - Ordinary Shares (NVS)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NVS on NYSE
CUSIP
66987V109
Type / Class
Equity / Ordinary Shares
Shares outstanding
2.18B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
134M
Holdings value
$17.2B
% of all portfolios
0.032%
Grand Portfolio weight change
+0%
Number of holders
1371
Number of buys
569
Number of sells
-546
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NOVARTIS AG - Ordinary Shares (NVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 6.4% $16.9B 140M UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sep 30, 2024

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 134M $17.2B +$51.5M $128.24 1,371
2025 Q2 133M $16.1B -$491M $121.01 1,369
2025 Q1 138M $15.3B +$873M $111.48 1,335
2024 Q4 130M $12.7B -$227M $97.31 1,322
2024 Q3 132M $15.2B -$630M $115.02 1,298
2024 Q2 138M $14.7B -$144M $106.46 1,296
2024 Q1 140M $13.6B -$108M $96.73 1,233
2023 Q4 141M $14.2B -$811M $100.97 1,254
2023 Q3 148M $15.1B -$2.43M $101.86 1,205
2023 Q2 148M $14.9B -$1.63B $100.91 1,182
2023 Q1 162M $14.9B -$603M $92.00 1,156
2022 Q4 171M $15.5B -$871M $90.72 1,172
2022 Q3 180M $13.6B -$1.52B $76.01 1,070
2022 Q2 199M $16.9B -$492M $84.53 1,123
2022 Q1 208M $18.3B -$256M $87.75 1,121
2021 Q4 211M $18.4B -$794M $87.47 1,135
2021 Q3 220M $18B +$259M $81.78 1,069
2021 Q2 217M $19.8B -$97M $91.24 1,112
2021 Q1 218M $18.6B -$804M $85.48 1,127
2020 Q4 228M $21.5B +$231M $94.43 1,169
2020 Q3 226M $19.7B -$1B $86.96 1,111
2020 Q2 238M $20.7B -$820M $87.34 1,125
2020 Q1 247M $20.4B -$921M $82.45 1,124
2019 Q4 257M $24.4B +$1.32B $94.69 1,162
2019 Q3 244M $21.2B -$1.14B $86.90 1,087
2019 Q2 257M $23.5B -$1.43B $91.31 1,091
2019 Q1 274M $26.2B +$86M $96.14 1,124
2018 Q4 273M $23.4B +$1.02B $85.81 1,080
2018 Q3 260M $22.4B +$468M $86.16 1,014
2018 Q2 255M $19.3B +$304M $75.54 977
2018 Q1 256M $20.7B +$333M $80.85 1,004
2017 Q4 250M $21B -$565M $83.96 1,000
2017 Q3 258M $22.1B -$116M $85.85 933
2017 Q2 259M $21.6B -$334M $83.47 916
2017 Q1 269M $20B +$1.29B $74.27 903
2016 Q4 252M $18.3B +$923M $72.84 902
2016 Q3 238M $18.8B +$43.9M $78.96 869
2016 Q2 235M $19.4B -$248M $82.51 871
2016 Q1 226M $16.4B +$176M $72.44 862
2015 Q4 236M $20.3B +$4.58M $86.04 923
2015 Q3 234M $21.5B +$238M $91.92 920
2015 Q2 235M $23.1B +$111M $98.34 939
2015 Q1 234M $23.1B -$44.1M $98.61 932
2014 Q4 235M $21.7B +$102M $92.66 907
2014 Q3 230M $21.7B -$346M $94.13 867
2014 Q2 236M $21.4B -$158M $90.53 845
2014 Q1 237M $20.2B -$336M $85.02 826